MPWM Advisory Solutions’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.55K Hold
260
0.01% 344
2025
Q4
$13.2K Hold
260
0.01% 295
2025
Q3
$14.4K Hold
260
0.01% 263
2025
Q2
$17.9K Hold
260
0.01% 247
2025
Q1
$18.1K Hold
260
0.01% 256
2024
Q4
$22.4K Buy
+260
New +$28.1K 0.02% 231

Other funds holding NVO

MPWM Advisory Solutions's NVO Position: Q1 2026 in Review

MPWM Advisory Solutions held its Novo Nordisk (NVO) position steady in Q1 2026 at 260 shares worth $9.55K. The position accounts for 0.01% of the portfolio, ranked #344.

MPWM Advisory Solutions first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $22.4K in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • MPWM Advisory Solutions held 260 shares of Novo Nordisk worth $9.55K as of Q1 2026.
  • MPWM Advisory Solutions left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up 0.01% of MPWM Advisory Solutions's portfolio in Q1 2026, its #344 holding.
  • MPWM Advisory Solutions first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • MPWM Advisory Solutions's Novo Nordisk position peaked at $22.4K in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on MPWM Advisory Solutions's 13F filing for Q1 2026, filed 13 May 2026.